Established supplements like berberine have decades of research
"And remember these are associations, not causations, so it's not to say that GLP-1 use causes NAION or worsening retinopathy, but their use is associated with these conditions." "From an ophthalmologic standpoint, these findings underscore the importance of baseline and follow-up eye examinations for patients starting GLP-1 therapy, especially those with pre-existing retinal or optic nerve risk factors." The expert added that while the benefits of GLP-1 medications in reducing cardiovascular and metabolic risks are "substantial," patients should be counseled on potential visual side effects, and "any sudden visual symptoms should prompt immediate ophthalmic referral." For more Health articles, visit www.foxnews.com/health Novo Nordisk, maker of Ozempic and Wegovy, provided the following statement when contacted by Fox News Digital
[21] Obesity [edit] Liraglutide may also be used together with diet and exercise for chronic weight management in adults
Deficiency of the oxygen sensor PHD1 augments liver regeneration after partial hepatectomy
"Based on the evidence available today, I think it would be premature to assume GLP-1 medications are headed toward prohibition," Gross said
